Advertisement
Singapore markets close in 2 hours 37 minutes
  • Straits Times Index

    3,318.07
    +10.17 (+0.31%)
     
  • Nikkei

    39,103.22
    +486.12 (+1.26%)
     
  • Hang Seng

    18,852.00
    -343.60 (-1.79%)
     
  • FTSE 100

    8,370.33
    -46.12 (-0.55%)
     
  • Bitcoin USD

    69,402.64
    -547.19 (-0.78%)
     
  • CMC Crypto 200

    1,510.87
    +8.21 (+0.55%)
     
  • S&P 500

    5,307.01
    -14.40 (-0.27%)
     
  • Dow

    39,671.04
    -201.95 (-0.51%)
     
  • Nasdaq

    16,801.54
    -31.08 (-0.18%)
     
  • Gold

    2,365.20
    -27.70 (-1.16%)
     
  • Crude Oil

    77.04
    -0.53 (-0.68%)
     
  • 10-Yr Bond

    4.4340
    +0.0200 (+0.45%)
     
  • FTSE Bursa Malaysia

    1,628.31
    +6.22 (+0.38%)
     
  • Jakarta Composite Index

    7,222.38
    +36.34 (+0.51%)
     
  • PSE Index

    6,637.37
    +30.15 (+0.46%)
     

Sage Therapeutics to Participate in Upcoming May Investor Conferences

CAMBRIDGE, Mass., May 07, 2024--(BUSINESS WIRE)--Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will participate in the following upcoming investor conferences in May:

  • 2024 RBCCM Global Healthcare Conference (New York, NY): fireside chat on Tuesday, May 14, 2024 at 11:30 a.m. ET.

  • BofA Securities 2024 Health Care Conference (Las Vegas, NV): fireside chat on Wednesday, May 15, 2024 at 10:00 a.m. PT.

A live webcast of each presentation can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcasts will be available following the completion of the presentation and will be archived for up to 30 days.

ADVERTISEMENT

About Sage Therapeutics

Sage Therapeutics (Nasdaq: SAGE) is a biopharmaceutical company committed to our mission of pioneering solutions to deliver life-changing brain health medicines, so every person can thrive. Sage developed the only two FDA-approved treatments indicated for postpartum depression and is advancing a robust pipeline to target unmet needs in brain health. Sage was founded in 2010 and is headquartered in Cambridge, Mass. Find out more at www.sagerx.com or engage with us on Facebook, LinkedIn, Instagram, and X.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240507629601/en/

Contacts

Investor
Ashley Kaplowitz
786-252-1419
ashley.kaplowitz@sagerx.com

Media
Matthew Henson
917-930-7147
matthew.henson@sagerx.com